Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 1475 entries
View as:

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01363817 Org: User:
Start: 09/28/11 End: 02/07/18 Due: 02/07/19

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT06345183 Org: User:
Start: 02/19/24 End: 12/31/24 Due: 12/31/25

Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study

Phase: N/A Priority: Normal
NCT ID: NCT02546791 Org: User:
Start: 07/22/15 End: 03/29/17 Due: 03/29/18

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04026412 Org: User:
Start: 10/08/19 End: 11/26/24 Due: 11/26/25

A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04794010 Org: User:
Start: 12/22/20 End: 12/22/27 Due: 12/22/28

Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT00362713 Org: User:
Start: 03/31/07 End: 10/31/09 Due: 10/31/10

Diabetic Peripheral Neuropathic Pain (DPNP)

Phase: N/A Priority: Normal
NCT ID: NCT01314222 Org: User:
Start: 03/31/11 End: 07/31/12 Due: 07/31/13

A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06568458 Org: User:
Start: 09/19/24 End: 02/27/25 Due: 02/27/26

Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01017367 Org: User:
Start: 02/29/08 End: 05/31/09 Due: 05/31/10

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03487848 Org: User:
Start: 06/25/18 End: 09/17/20 Due: 09/17/21

Safety and Pharmacology Study of BMS-866949

Phase: N/A Priority: Normal
NCT ID: NCT01124344 Org: User:
Start: 05/31/10 End: 11/30/11 Due: 11/30/12

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Phase: N/A Priority: Normal
NCT ID: NCT02369653 Org: User:
Start: 10/22/15 End: 07/07/21 Due: 07/07/22

A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

Phase: N/A Priority: Normal
NCT ID: NCT02985957 Org: User:
Start: 03/26/17 End: 01/07/25 Due: 01/07/26

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Phase: N/A Priority: Normal
NCT ID: NCT00423319 Org: User:
Start: 03/31/07 End: 09/30/09 Due: 09/30/10

Safety Study of Abatacept to Treat Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01247766 Org: User:
Start: 12/31/10 End: 12/31/14 Due: 12/31/15

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Phase: N/A Priority: Normal
NCT ID: NCT05577715 Org: User:
Start: 11/14/22 End: 08/12/24 Due: 08/12/25

A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection

Phase: N/A Priority: Normal
NCT ID: NCT02496078 Org: User:
Start: 08/31/15 End: 02/28/17 Due: 02/28/18

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00983957 Org: User:
Start: 10/31/09 End: 02/28/10 Due: 02/28/11

A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05899738 Org: User:
Start: 05/18/23 End: 07/06/23 Due: 07/06/24

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06253221 Org: User:
Start: 04/17/24 End: 03/28/31 Due: 03/28/32

A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05093790 Org: User:
Start: 03/25/22 End: 11/14/22 Due: 11/14/23

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03329846 Org: User:
Start: 11/30/17 End: 07/02/20 Due: 07/02/21

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT01450761 Org: User:
Start: 12/13/11 End: 05/17/17 Due: 05/17/18

Yervoy Pregnancy Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT02854488 Org: User:
Start: 09/30/16 End: 03/05/21 Due: 03/05/22

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00397566 Org: User:
Start: 02/28/07 End: 02/28/07 Due: 02/28/08